SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-074840
Filing Date
2022-06-27
Accepted
2022-06-27 17:12:34
Documents
17
Period of Report
2022-06-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2219459d1_8k.htm   iXBRL 8-K 32342
2 EXHIBIT 1.1 tm2219459d1_ex1-1.htm EX-1.1 317980
3 EXHIBIT 4.1 tm2219459d1_ex4-1.htm EX-4.1 97570
4 EXHIBIT 4.2 tm2219459d1_ex4-2.htm EX-4.2 94142
5 EXHIBIT 5.1 tm2219459d1_ex5-1.htm EX-5.1 77957
6 EXHIBIT 23.1 tm2219459d1_ex23-1.htm EX-23.1 33748
  Complete submission text file 0001104659-22-074840.txt   978272

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA aplt-20220622.xsd EX-101.SCH 3066
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE aplt-20220622_lab.xml EX-101.LAB 34476
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aplt-20220622_pre.xml EX-101.PRE 22617
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2219459d1_8k_htm.xml XML 3688
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 221045539
SIC: 2834 Pharmaceutical Preparations